Drug
Br005 036c
Br005 036c: highest development phase Phase 3, developed by Brise Pharmaceuticals Co., Ltd.. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Brise Pharmaceuticals Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BR005-036C NCT07835152 | Phase 3 | Migraine, With or Without Aura |
| BR005-036C NCT07792681 | Phase 2/3 | Migraine, With or Without Aura |
Latest
No recent events.
Follow Br005 036c on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.